PP_1170x120_10-25-21

Alliance for Pharmacy Compounding

With amoxicillin in shortage, FDA looks to compounders

With amoxicillin in shortage, FDA looks to compounders

ALEXANDRIA, Va. — With amoxocillin suspension on FDA’s drug shortage list, on Friday the agency released a final guidance documentstipulating minimum steps pharmacies that compound beta lactam oral antibiotic suspension products must take to mitigate the potential for cross-contamination with other products The steps include only compounding from FDA-approved beta-lactam tablets and capsules instead of

FDA concedes in compounding MOU litigation

FDA concedes in compounding MOU litigation

ALEXANDRIA, Va. — In a significant legal victory for pharmacy compounders, the U.S. Food & Drug Administration has conceded that it must conduct formal notice-and-comment rulemaking to implement its memorandum of understanding with states regarding interstate shipments of compounded medications. The agency concession is related to a lawsuit, Wellness Pharmacy v. Azar, brought in federal court against

New report shares data on pharmacy compounders

New report shares data on pharmacy compounders

ALEXANDRIA, Va. — Pharmacy compounding plays a critical role not only in Americans’ healthcare, but in the economic health of communities across the country. Those are some takeaways from the first-ever “Snapshot of Pharmacy Compounding in America 2021,” released today by the Alliance for Pharmacy Compounding. Some key statistics: During the pandemic, 67 % of

Tricare steps back from compounding recoupment

Tricare steps back from compounding recoupment

ALEXANDRIA, Va. – An egregious Tricare/Express Scripts (ESI) recoupment faced by hundreds of compounding pharmacies across the country is ending, thanks to the work of two industry trade associations, the Alliance for Pharmacy Compounding and the National Community Pharmacists Association. It began back in June, when about 400 compounding pharmacies across the U.S. received a

Pharmacy groups urge “fundamental reshaping” of health care vertical merger policy

Pharmacy groups urge “fundamental reshaping” of health care vertical merger policy

ALEXANDRIA, Va.  – The Alliance for Pharmacy Compounding, American Pharmacists Association, American Society of Consultant Pharmacists, National Alliance of State Pharmacy Associations, and National Community Pharmacists Association collectively urged “reinvigorated and reimagined antitrust enforcement policy” in joint comments submitted Wednesday to the Federal Trade Commission and the Department of Justice Antitrust Division. Earlier this year,

Shawn Hodges named president of Alliance for Pharmacy Compounding

Shawn Hodges named president of Alliance for Pharmacy Compounding

KENNESAW, Ga.— The Alliance for Pharmacy Compounding (formerly IACP) has named Shawn Hodges, president and CEO of Innovation Compounding, as its 2020 president. Alliance for Pharmacy Compounding is a professional advocacy organization focused solely on pharmacy compounding and public policy advocacy. The organization works directly with legislators, regulators, and policymakers at both the state and national levels

Adheris Health